A Genetic Variant in Primary miR-378 Is Associated with Risk and Prognosis of Hepatocellular Carcinoma in a Chinese Population

MicroRNA Expression Profiling of Oral Carcinoma Identifies New Markers of Tumor Progression

(2017) L. Scapoli et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

A potentially functional polymorphism in the promoter region of let-7 family is associated with survival of hepatocellular carcinoma

(2013) Kaipeng Xie et al.   Cancer Epidemiology

Sirtuin-6-dependent genetic and epigenetic alterations are associated with poor clinical outcome in hepatocellular carcinoma patients

(2013) Jens U. Marquardt et al.   HEPATOLOGY

CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma

(2012) J Tang et al.   CELL DEATH AND DIFFERENTIATION

Dysregulated Krüppel-Like Factor 4 and Vitamin D Receptor Signaling Contribute to Progression of Hepatocellular Carcinoma

(2012) Qi Li et al.   GASTROENTEROLOGY

The value of the Barcelona Clinic Liver Cancer and alpha-fetoprotein in the prognosis of hepatocellular carcinoma

(2012) Rafael Gómez-Rodríguez et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

(2011) Jipeng Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma

(2011) Jin Hou et al.   CANCER CELL

MicroRNA-Based Classification of Hepatocellular Carcinoma and Oncogenic Role of miR-517a

(2011) Sara Toffanin et al.   GASTROENTEROLOGY

Management of hepatocellular carcinoma: An update

(2011) Jordi Bruix et al.   HEPATOLOGY

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development

(2011) Lingmin Hu et al.   HEPATOLOGY

p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor

(2011) B Testoni et al.   ONCOGENE

Genetic Polymorphisms in the Precursor MicroRNA Flanking Region and Non–Small Cell Lung Cancer Survival

(2010) Zhibin Hu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy

(2010) Augusto Villanueva et al.   Annual Review of Medicine

miR-378 ∗ Mediates Metabolic Shift in Breast Cancer Cells via the PGC-1β/ERRγ Transcriptional Pathway

(2010) Lillian J. Eichner et al.   Cell Metabolism

MicroRNAs control hepatocyte proliferation during liver regeneration

(2010) Guisheng Song et al.   HEPATOLOGY

A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma

(2010) Yan Xu et al.   INTERNATIONAL JOURNAL OF CANCER

Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis

(2010) Ying Xin WANG et al.   Journal of Digestive Diseases

Human CYP2E1 is regulated by miR-378

(2009) Takuya Mohri et al.   BIOCHEMICAL PHARMACOLOGY

An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1  3' untranslated region confers risk for hepatocellular carcinoma

(2009) Y. Gao et al.   CARCINOGENESIS

Liver cancer: Descriptive epidemiology and risk factors other than HBV and HCV infection

(2008) Shu-Chun Chuang et al.   CANCER LETTERS

Role of microRNAs in vascular diseases, inflammation, and angiogenesis

(2008) C. Urbich et al.   CARDIOVASCULAR RESEARCH

Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues

(2008) Junming Guo et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY